Pfizer P/B Ratio
Pfizer (PFIZER) P/B ratio is 4.4 (High), book value per share ₹913.70 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Pfizer screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PFIZER P/B Ratio — Valuation Insights & Book Value Analysis
Pfizer price-to-book ratio interpretation, valuation status and historical context — current P/B 4.4 (High). Read PFIZER dividend history for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 4.4, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 26.2% below historical average
- Trading at premium to sector average PB of -0.01
Pfizer P/B Ratio Historical Trend
PFIZER annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore PFIZER intrinsic value to estimate fundamental worth using multiple valuation models.
PFIZER Historical P/B Ratio — Book Value Per Share & Year-End Price
Pfizer annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 4.38 | ₹913.7 | ₹4002.40 | ₹4,203 | High |
| 2025 | 5.44 | ₹916.74 | ₹4987.70 | ₹4,217 | High |
| 2024 | 6.76 | ₹781.74 | ₹5281.50 | ₹3,596 | High |
| 2023 | 6.12 | ₹697.17 | ₹4268.95 | ₹3,207 | High |
| 2022 | 7.12 | ₹622.61 | ₹4431.70 | ₹2,864 | High |
PFIZER vs Healthcare Peers — P/B Ratio Comparison
Pfizer P/B 4.4 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |